Hypofractionated stereotactic boost in intermediate risk prostate carcinoma: Preliminary results of a multicenter phase II trial (CKNO-PRO)

PURPOSE: Dose escalation may improve curability in intermediate-risk prostate carcinoma. A multicenter national program was developed to assess toxicity and tumor response with hypofractionated stereotactic boost after conventional radiotherapy in intermediate-risk prostate cancer. METHODS AND MATER...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:PLoS One
Autori principali: Pasquier, David, Nickers, Philippe, Peiffert, Didier, Maingon, Philippe, Pommier, Pascal, Lacornerie, Thomas, Martinage, Geoffrey, Tresch, Emmanuelle, Lartigau, Eric
Natura: Artigo
Lingua:Inglês
Pubblicazione: Public Library of Science 2017
Soggetti:
Research Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5708754/
https://ncbi.nlm.nih.gov/pubmed/29190707
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0187794
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi